Researchers from MIT and elsewhere have developed a swallowable “technopill” that can monitor vital signs from inside the body, reports Dennis Thompson for HealthDay. “The ability to facilitate diagnosis and monitor many conditions without having to go into a hospital can provide patients with easier access to healthcare and support treatment,” says Prof. Giovanni Traverso.
Forbes reporter Nancy Wang spotlights Tara Bishop '97 and Eileen Tanghal '97, co-founders of Black Opal Ventures, a venture capital firm focused on health tech. “Tara and Eileen’s story at Black Opal Ventures is a testament to how diversity and innovation can disrupt traditional landscapes,” writes Wang. “Their pioneering strategies and investments herald a new era for healthcare venture capitalism, where diversity and technology converge to create a more inclusive and impactful future.”
Principal Research Scientist Emre Gençer speaks with The Independent reporter Louise Boyle about natural hydrogen and its potential as a future renewable energy source. “There is a ‘mismatch’ where natural hydrogen is being discovered and where it could be used, which would require massive investments in completely new infrastructure,” says Gençer. “I think it will be part of the solution but we need to take it with a grain of salt.”
MIT researchers have developed a supercapacitor comprised of concrete and charcoal, that can store electricity and discharge as needed, reports Aleks Phillips for Newsweek. Researchers hope the device can provide “a cheap and architectural way of saving renewable energy from going to waste,” writes Phillips.
Prof. Russ Tedrake and Max Bajracharya '21 MEng '21 speak with TechCrunch reporter Brian Heater about the impact of generative AI on the future of robotics. “Generative AI has the potential to bring revolutionary new capabilities to robotics,” says Tedrake. “Not only are we able to communicate with robots in natural language, but connecting to internet-scale language and image data is giving robots a much more robust understanding and reasoning about the world.”
New Scientist reporter Alice Klein writes that MIT researchers have developed an ingestible electronic device that “can measure your breathing and heart rate from inside your gut [and] could potentially diagnose sleep apnea and even detect opioid overdoses.” The device could one day allow “people to be assessed for sleep apnea wirelessly and cheaply while at home.”
Researchers at MIT and elsewhere have developed a new type of cancer treatment – a gel that can be used to deliver cancer drugs for solid tumors, reports WHDH. “It’s really transformative to try and help patients whose tumors are very resistant to therapy,” says Prof. Giovanni Traverso.
Prof. Gio Traverso speaks with Lizzy Lawler at STAT about a new ingestible sensor that monitors a person’s heart and breathing rates to detect sleep disorders. “The vision for sleep evaluation is the ability to detect these events wherever you are in the nation, and not having to go to a sleep lab and an inpatient setting,” says Traverso.
A team including researchers from MIT have developed a new ingestible ‘smart capsule’ that uses a patient’s vital signs to detect sleep disorders or opioid overdoses. “The findings suggest that the ingestible was able to measure health metrics on par with medical-grade diagnostic equipment at the sleep center,” writes Malak Saleh for Engadget.
Prof. Emeritus Olivier Blanchard speaks with Robert Armstrong of the Financial Times about inflation, the rise in long yields and the fiscal endgame in the U.S. Blanchard urges regulators to, “have plans for a steady reduction of primary deficits to close to zero. Slow, steady, convincing, credible.”
Researchers at MIT and elsewhere have developed a swallowable electronic capsule that can be used to help diagnose sleep apnea and other sleep disorders, reports Ian Randall for Newsweek. “Conventional laboratory and home sleep studies require the patient to be attached to many different sensors,” says Prof. Giovanni Traverso. “As you can imagine, trying to sleep with all of this machinery can be challenging. [The] ingestible capsule just requires that the patient swallow the vitamin-sized pill. It's easy and unobtrusive and can accurately measure both respiratory rate and heart rate while the patient sleeps."
Prof. Tavneet Suri discusses GiveDirectly, the world’s largest universal basic income (UBI) program, which has been providing almost 5,000 people in Kenya with “a payment of about 75 cents (62p) a day since 2017,” reports Philippa Kelley for The Guardian. “We do see people leaving low wage jobs,” says Suri. “They are going and starting businesses, and the businesses are doing great because there’s money around.”
Johanna Mayer and Katie Hafner from Scientific American’s “The Lost Women of Science podcast spotlight the late former Prof. Mária Telkes and her work focused on the development of solar energy. “Dr. Mária Telkes died in 1995, at age 94,” says Mayer. “But her legacy lives on. Today, the number of people installing solar panels in their homes is consistently rising – and in a recent Pew study, 39% of homeowners surveyed said they were seriously considering going solar.”
Principal Research Scientist Andrew McAfee speaks with CNBC about the contributing factors to a successful start-up company. “Incumbent industries and companies are so fond of really elaborate planning cycles and the geeks just build things, get feedback and do again on a fast cadence,” says McAfee.